Development of second-generation indole-based dynamin GTPase inhibitors.

JOURNAL OF MEDICINAL CHEMISTRY(2013)

引用 37|浏览7
暂无评分
摘要
Focused library development of our lead 2-cyano-3-(1-(3-(dimethylamino)-propyl)-2-methyl-1H-indol-3-yl)-N-octylacrylamide (2) confirmed the tertiary dimethylamino-propyl moiety as critical for inhibition of dynamin GTPase. The cyanoamide moiety could be replaced with a thiazole-4(5H)-one isostere (19, IC50(dyn I) = 7.7 mu M), reduced under flow chemistry conditions (20, IC50(dyn I) = 5.2 mu M) or replaced by a simple amine. The latter provided a basis for a high yield library of compounds via a reductive amination by flow hydrogenation. Two compounds, 24 (IC50(dyn I) = 0.56 mu M) and 25 (IC50(dyn I) = 0.76 mu M), stood out. Indole 24 is nontoxic and showed increased potency against dynamin I and II in vitro and in cells (IC50(CME) = 1.9 mu M). It also showed 4.4-fold selectivity for dynamin I. The indole 24 compound has improved isoform selectivity and is the most active in-cell inhibitor of clathrin-mediated endocytosis reported to date.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要